Watch this space. When a globally-respected investment fund like Highbridge takes a position in an all-but-forgotten, ultra-micro biotech that's trading at .10 cents, you know they see value. My reading is they are about to take a much bigger stake by buying on market.
Higghbridge Capital update, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
